Aerie Pharma (AERI) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
Aerie Pharma (AERI) PT Lowered to $24 at Needham & Company
August 5, 2021 6:37 AM EDTNeedham & Company analyst Serge Belanger lowered the price target on Aerie Pharma (NASDAQ: AERI) to $24.00 (from $26.00) while maintaining a Buy rating.
The analyst commented, "AERI reported solid 2Q21 earnings with glaucoma sales of $27.2MM (+18%Q/Q and +51%Y/Y) that outpaced Street... More
